title: Structure, dynamics and selectivity in the sulfotransferase family.
abstract: Combined structure, function and molecular dynamics studies of human cytosolic sulfotransferases (SULT1A1 and 2A1) have revealed that these enzymes contain a ≈ 30-residue active-site cap whose structure responds to substrates and mediates their interactions. The binding of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) gates access to the active site by a remodeling of the cap that constricts the pore through which acceptors must pass to enter the active site. While the PAPS-bound enzyme spends the majority (≈ 95%) of its time in the constricted state, the pore isomerizes between the open and closed states when the nucleotide (PAPS) is bound. The dimensions of the open and closed pores place widely different steric constraints on substrate selectivity. Nature appears to have crafted these enzymes with two specificity settings - a closed-pore setting that admits a set of closely related structures, and an open setting that allows a far wider spectrum of acceptor geometries. The specificities of these settings seem well matched to the metabolic demands for homeostatic and defensive SULT functions. The departure of nucleotide requires that the cap open. This isomerization dependent release can explain both the product bursts and substrate inhibition seen in many SULTs. Here, the experimental underpinnings of the cap-mechanism are reviewed, and the advantages of such a mechanism are considered in the context of the cellular and metabolic environment in which these enzymes operate.
authors.affiliation: Department of Microbiology and Immunology, Albert Einstein College of Medicine , Bronx, NY , USA.
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Leyh
authors.forename: Ian
authors.initials: I
authors.lastname: Cook
authors.forename: Ting
authors.initials: T
authors.lastname: Wang
mesh_terms: D000818:Animals; D001665:Binding Sites; D003600:Cytosol / Q000201:enzymology*; D006801:Humans; D056004:Molecular Dynamics Simulation; D011485:Protein Binding; D013379:Substrate Specificity; D015238:Sulfotransferases / Q000737:chemistry / Q000235:genetics / Q000502:physiology
chemical_list: D015238:Sulfotransferases
references.citation: Nat Struct Biol. 1997 Nov;4(11):904-8
references.pmid: 9360604
references.citation: Steroids. 1998 May-Jun;63(5-6):322-8
references.pmid: 9618795
references.citation: Biochemistry. 2010 Jun 15;49(23):4779-85
references.pmid: 20429582
references.citation: FEBS Lett. 2001 Feb 9;490(1-2):39-43
references.pmid: 11172807
references.citation: Biochemistry. 2012 Jul 17;51(28):5674-83
references.pmid: 22703301
references.citation: J Biol Chem. 2003 Feb 28;278(9):7655-62
references.pmid: 12471039
references.citation: Atherosclerosis. 2011 Feb;214(2):350-6
references.pmid: 21146170
references.citation: Biochim Biophys Acta. 2006 Dec;1761(12):1515-22
references.pmid: 17055780
references.citation: Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):635-46
references.pmid: 22512672
references.citation: Biochemistry. 2008 Nov 11;47(45):11894-9
references.pmid: 18928301
references.citation: J Biol Chem. 1998 May 1;273(18):10888-92
references.pmid: 9556564
references.citation: J Biol Chem. 1981 Nov 10;256(21):11123-7
references.pmid: 6945304
references.citation: J Biol Chem. 2009 Oct 23;284(43):29357-64
references.pmid: 19706609
references.citation: PLoS One. 2011;6(11):e26794
references.pmid: 22069470
references.citation: Bull Environ Contam Toxicol. 1993 Sep;51(3):361-6
references.pmid: 8219590
references.citation: J Anim Sci. 1995 Jan;73(1):21-8
references.pmid: 7601736
references.citation: Breast Cancer Res Treat. 2002 Jul;74(2):167-76
references.pmid: 12186377
references.citation: Ann N Y Acad Sci. 2002 May;957:21-36
references.pmid: 12074959
references.citation: FEBS Lett. 2000 Jun 9;475(1):61-4
references.pmid: 10854859
references.citation: Drug Metab Dispos. 2009 Oct;37(10):2069-78
references.pmid: 19589875
references.citation: Horm Mol Biol Clin Investig. 2010;1(2):81-87
references.pmid: 21822452
references.citation: Wien Med Wochenschr. 2006 Jul;156(13-14):380-5
references.pmid: 16937039
references.citation: Clin Pharmacol Ther. 1983 Apr;33(4):529-36
references.pmid: 6831833
references.citation: Toxicol Sci. 2006 Oct;93(2):242-55
references.pmid: 16807285
references.citation: Endocr Rev. 1997 Jun;18(3):378-403
references.pmid: 9183569
references.citation: Food Chem Toxicol. 2011 Dec;49(12):3287-309
references.pmid: 21906651
references.citation: FEBS J. 2005 Mar;272(5):1179-88
references.pmid: 15720392
references.citation: Chem Biol Interact. 1998 Feb 20;109(1-3):329-39
references.pmid: 9566756
references.citation: Arch Biochem Biophys. 1990 May 1;278(2):312-8
references.pmid: 2327787
references.citation: J Biol Chem. 2005 Dec 16;280(50):41482-6
references.pmid: 16221673
references.citation: Biochem J. 2002 May 15;364(Pt 1):165-71
references.pmid: 11988089
references.citation: J Natl Cancer Inst. 2007 Mar 7;99(5):350-6
references.pmid: 17341726
references.citation: J Biol Chem. 2013 Mar 22;288(12):8619-8626
references.pmid: 23362278
references.citation: Lab Invest. 1985 Nov;53(5):534-40
references.pmid: 2414564
references.citation: J Chem Inf Comput Sci. 2004 May-Jun;44(3):793-806
references.pmid: 15154744
references.citation: Biochemistry. 2013 Jan 15;52(2):415-24
references.pmid: 23256751
references.citation: FASEB J. 1997 Mar;11(4):206-16
references.pmid: 9068609
references.citation: Biochem Biophys Res Commun. 2010 May 28;396(2):429-34
references.pmid: 20417180
references.citation: Arch Biochem Biophys. 2011 Mar 15;507(2):232-40
references.pmid: 21187059
references.citation: Biochem J. 2007 Jun 1;404(2):207-15
references.pmid: 17335415
references.citation: Endocrinology. 1996 Apr;137(4):1395-401
references.pmid: 8625916
references.citation: Am J Obstet Gynecol. 1973 Nov 1;117(5):631-42
references.pmid: 4742372
references.citation: Oncogene. 2006 Mar 13;25(11):1673-8
references.pmid: 16550167
references.citation: J Biol Chem. 2004 Jan 23;279(4):2689-96
references.pmid: 14573603
references.citation: Age Ageing. 1992 Nov;21(6):417-20
references.pmid: 1471579
references.citation: J Biol Chem. 2003 Jul 4;278(27):24243-6
references.pmid: 12730193
references.citation: FASEB J. 1997 May;11(6):404-18
references.pmid: 9194521
references.citation: Biochem J. 1989 Jun 15;260(3):641-6
references.pmid: 2764897
references.citation: Am J Physiol. 1963 Apr;204:626-40
references.pmid: 13949263
references.citation: J Steroid Biochem Mol Biol. 1999 Feb;68(3-4):137-44
references.pmid: 10369411
references.citation: Drug Metab Dispos. 2006 Mar;34(3):361-8
references.pmid: 16381672
references.citation: Xenobiotica. 2002 Oct;32(10):849-62
references.pmid: 12419015
references.citation: J Biol Chem. 2002 May 17;277(20):17928-32
references.pmid: 11884392
references.citation: Mol Pharmacol. 2008 Mar;73(3):660-8
references.pmid: 18042734
references.citation: Pflugers Arch. 1991 Jun;418(5):519-21
references.pmid: 1891339
references.citation: PLoS Biol. 2007 May;5(5):e97
references.pmid: 17425406
references.citation: Drug Metab Dispos. 2009 Nov;37(11):2255-61
references.pmid: 19679676